Aspira Pathlab & Diagnostics share news and announcements
BSE: 540788Healthcare ServicesSmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹123.45.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹130 Cr3,082nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 23 May 2026
- 10.6
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 12 Aug 2026
- −3.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Aug 2026
- −4.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 23 May 2026
- 0.11
- Volume, BSEVolume. Shares traded on the last trading day.
- 352
Aspira Pathlab & Diagnostics share news and announcements
520 announcements, routine notices left out, newest first. Page 11 of 11.
Apr 2018
24 Apr · Compliance Certificate For The Period Ended March 31, 2018
18 Apr · Board Meeting On 21St April, 2018
17 Apr · Shareholding for the Period Ended March 31, 2018
Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click ....16 Apr · Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Mar 2018
30 Mar · Announcement under Regulation 30 (LODR)-Public Announcement-Delisting
Feb 2018
27 Feb · Announcement under Regulation 30 (LODR)-Change in RTA
5 Feb · Financial Report For The Quarter Ended 31St December, 2017
5 Feb · Outcome of Committee Meeting
5 Feb · Board meeting
Jan 2018
29 Jan · Meeting Of Audit Committee And Independent Director On 5Th February, 2018.
23 Jan · Board Meeting on Feb 05, 2018 (To consider voluntary delisting from CSE and Metropolitan Stock Exchange)
15 Jan · Shareholding for the Period Ended December 31, 2017
Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click ....12 Jan · Statement Of Investor Complaints For The Quarter Ended 31St December, 2017
Dec 2017
5 Dec · Listing of equity shares of Aspira Pathlab & Diagnostics Ltd
Trading Members of the Exchange are hereby informed that effective from December 05, 2017, the equity shares of Aspira Pathlab & Diagnostics Ltd (Scrip Code: 540788) are listed and admitted ....